While these medicines are generally safe, many people have reported some side effects 1 , especially during the early stages of treatment 2
Compared to Semaglutide 2.4mg (marketed as Wegovy), Retatrutide 12mg produces 62% greater weight reduction
Lack of transparency about compounding pharmacies
GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet cells, promotion of islet cell proliferation, and minimal side effects
As a result, some patients may have been misclassified if PCOS was listed as a secondary or historical condition rather than an active clinical diagnosis
In the STEP 1 trial, semaglutide produced substantial weight loss, of which approximately 30% was attributed to lean tissue, while fat loss predominated [21, 22]